Article
Luspatercept ameliorates disease phenotype and complications in the Townes mouse model of sickle cell disease.
The Journal of clinical investigation - 2 Feb 2026
Sezaki Maiko, Li Tian, Pan Mingzhe, Wang Zhihong, Bai Jie, Horowitz Justin G, Xu Julia Z, Huang Gang
Abstract excerpt
Preclinical data demonstrating that luspatercept mitigates vaso-occlusive and anemia-related complications in the Townes sickle cell model provide a strong rationale for its evaluation in SCD patients.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
